These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34089409)

  • 1. Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trial.
    McClure NS; Paulden M; Ohinmaa A; Johnson JA
    Eur J Health Econ; 2021 Dec; 22(9):1441-1451. PubMed ID: 34089409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes.
    McClure NS; Sayah FA; Ohinmaa A; Johnson JA
    Value Health; 2018 Sep; 21(9):1090-1097. PubMed ID: 30224114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
    Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
    Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of Quality-Adjusted Life-Year Loss for Injuries in the United States.
    Raich W; Baxter J; Sheahan M; Goldhaber-Fiebert J; Sullivan P; Hanmer J
    Med Decis Making; 2023 Apr; 43(3):288-298. PubMed ID: 36482721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HubBLe Trial: haemorrhoidal artery ligation (HAL) versus rubber band ligation (RBL) for symptomatic second- and third-degree haemorrhoids: a multicentre randomised controlled trial and health-economic evaluation.
    Brown S; Tiernan J; Biggs K; Hind D; Shephard N; Bradburn M; Wailoo A; Alshreef A; Swaby L; Watson A; Radley S; Jones O; Skaife P; Agarwal A; Giordano P; Lamah M; Cartmell M; Davies J; Faiz O; Nugent K; Clarke A; MacDonald A; Conaghan P; Ziprin P; Makhija R
    Health Technol Assess; 2016 Nov; 20(88):1-150. PubMed ID: 27921992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for degenerative cervical myelopathy: a patient-centered quality of life and health economic evaluation.
    Witiw CD; Tetreault LA; Smieliauskas F; Kopjar B; Massicotte EM; Fehlings MG
    Spine J; 2017 Jan; 17(1):15-25. PubMed ID: 27793760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.
    Davis JC; Liu-Ambrose T; Khan KM; Robertson MC; Marra CA
    Osteoporos Int; 2012 Jul; 23(7):1849-57. PubMed ID: 21909728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?
    Barton GR; Sach TH; Jenkinson C; Avery AJ; Doherty M; Muir KR
    Health Qual Life Outcomes; 2008 Jul; 6():51. PubMed ID: 18625052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
    King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
    Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of influenza on health-related quality of life among confirmed (H1N1)2009 patients.
    Hollmann M; Garin O; Galante M; Ferrer M; Dominguez A; Alonso J
    PLoS One; 2013; 8(3):e60477. PubMed ID: 23555979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
    Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals.
    Pennington BM
    Value Health; 2020 Oct; 23(10):1349-1357. PubMed ID: 33032779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.
    Pavey TG; Anokye N; Taylor AH; Trueman P; Moxham T; Fox KR; Hillsdon M; Green C; Campbell JL; Foster C; Mutrie N; Searle J; Taylor RS
    Health Technol Assess; 2011 Dec; 15(44):i-xii, 1-254. PubMed ID: 22182828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.